These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring]. Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A Psychiatr Pol; 1994; 28(1):17-26. PubMed ID: 8190816 [TBL] [Abstract][Full Text] [Related]
3. Plasma drug levels and clinical response to antidepressants. Simpson GM; Pi EH; White K J Clin Psychiatry; 1983 May; 44(5 Pt 2):27-34. PubMed ID: 6343361 [TBL] [Abstract][Full Text] [Related]
4. [Clinical pharmacokinetics of tricyclic antidepressants. Part I. Pharmacokinetic properties]. Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A Psychiatr Pol; 1993; 27(6):683-91. PubMed ID: 8134502 [TBL] [Abstract][Full Text] [Related]
5. Monitoring of antidepressant drug plasma levels: the next ten years. Sjöqvist F Prog Neuropsychopharmacol; 1979; 3(1-3):201-10. PubMed ID: 401339 [TBL] [Abstract][Full Text] [Related]
9. The mechanism of action of antidepressants: a unitary hypothesis based on transport-p. Al-Damluji S Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):201-16. PubMed ID: 15180481 [TBL] [Abstract][Full Text] [Related]
11. Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation. Sjöqvist F; Bertilsson L Prog Clin Biol Res; 1986; 214():169-88. PubMed ID: 3523507 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic monitoring of tricyclic antidepressant drugs]. Grzesiak M; Beszłej JA; Szewczuk-Bogusławska M Psychiatr Pol; 2003; 37(5):825-37. PubMed ID: 14631602 [TBL] [Abstract][Full Text] [Related]
13. Drug level monitoring in psychopharmacology: usefulness and clinical problems, with special reference to tricyclic antidepressants. Gram LF; Pedersen OL; Kristensen CB; Bjerre M; Kragh-Sørensen P Ther Drug Monit; 1982; 4(1):17-25. PubMed ID: 7041335 [TBL] [Abstract][Full Text] [Related]
14. Tricyclic antidepressants: contemporary issues for therapeutic practice. Pollock BG; Perel JM Can J Psychiatry; 1989 Aug; 34(6):609-17. PubMed ID: 2670183 [TBL] [Abstract][Full Text] [Related]
15. [New antidepressive drugs in comparison with classical tricyclics. Mechanism of action and clinical evaluation]. Broocks A; Junghanns K; Thiel A; Gleiter CH; Bandelow B Fortschr Neurol Psychiatr; 2000 Jan; 68(1):17-24. PubMed ID: 10705571 [TBL] [Abstract][Full Text] [Related]
16. Tricyclic antidepressants in treatment of the elderly. Hall RC; Beresford TP Geriatrics; 1984 Apr; 39(4):81-3, 86-8, 90 passim. PubMed ID: 6706120 [No Abstract] [Full Text] [Related]
17. Tricyclic antidepressants: clinical use of plasma levels. Preskorn SH; Madakasira S J Kans Med Soc; 1981 Mar; 82(3):122-4, 134. PubMed ID: 7276685 [No Abstract] [Full Text] [Related]
18. [Pharmacological treatment of delusional depression]. Amore M; Giordani L; Giorgetti G; Zazzeri N Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants. Bagheri H; Picault P; Schmitt L; Houin G; Berlan M; Montastruc JL Br J Clin Pharmacol; 1994 Jan; 37(1):93-6. PubMed ID: 8148228 [TBL] [Abstract][Full Text] [Related]
20. Plasma-protein binding of tricyclic antidepressants. Braithwaite RA Postgrad Med J; 1980; 56 Suppl 1():107-11. PubMed ID: 6994085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]